Health Trials

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Phase 1 Clinical Study Comparing GS101 and Dupixent® After Subcutaneous Injection

This is a randomized, double-blind, three-arm, parallel-group study designed to demonstrate the similarity of the pharmacokinetics (PK), safety, and immunogenicity of GS101 injection compared with U.S. commercial Dupixent® and CN commercial Dupixent® in healthy adult participants in China. A total of 294 healthy male adult participants, with 98 participants per treatment group across 3 groups.

Participants needed: 294
Trial details
Phase: Phase 1Age: 18-55Biological sex: MaleType: InterventionalSponsor: Jiangsu Genscend Biopharmaceutical Co., LtdUpdated: May 20, 2026Locations: 1
Eligibility criteria

No clinically significant abnormalities detected in physical examination, vital... [+2]

History or presence at screening of neurological/psychiatric, respiratory, cardi... [+2]

Read more
Status: Not yet recruiting

A Phase III Study of GS101 Injection to Dupixent®

This is a a multicenter, randomized, double-blinded, parallel, positive-controlled, Phase III comparative study to evaluate GS101 Injection versus Dupixent® in participants with moderate-to-severe atopic dermatitis. A total of 572 subjects are planned to be included and randomized at a ratio of 1:1 to receive GS101 injection or Dupixent®

Participants needed: 572
Trial details
Phase: Phase 3Age: 18-75Biological sex: AllType: InterventionalSponsor: Jiangsu Genscend Biopharmaceutical Co., LtdUpdated: Feb 4, 2026Locations: 1
Eligibility criteria

Subjects, male or female, between the ages of 18 and 75 years (inclusive) [+2]

Hypersensitivity or known allergy to the investigational product(s) or any of th... [+2]

Read more